About us
News & Articles
Branding/Advertising
Business & Finance
Consumer Behavior & Market Insights
Events/Celebrations
Health/ Lifestyle & Entertainment
Latest from Marketing World
Market Data
Marketing Ethics
Marketing Guru Speaks
Marketing Research
Product Reviews
Sales and Distribution
Social Media Marketing
Market Intelligence & Research
Skilling Programs
Internship
Case studies
Contact Us
Contribute Articles
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Tuesday, December 9, 2025
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
Twitter
WhatsApp
About us
News & Articles
All
Branding/Advertising
Business & Finance
Consumer Behavior & Market Insights
Events/Celebrations
Business & Finance
Alldigi Tech, a Digitide Company, Recognized as Major Contender & Star Performer in Everest Group’s Multi-Country Payroll (MCP) PEAK Matrix® Assessment 2025
Branding/Advertising
9shines Label Creates a New Nightwear Category in India With 500+ Styles, Premium Craft & Modern Comfort
Business & Finance
Flam Appoints Rachit Jain as Head of GTM Strategy (Global) to Accelerate International Expansion
Events/Celebrations
Nalanda Literature Festival Partners with Nava Nalanda Mahavihara to Celebrate the Global ‘Nalanda Spirit’
Market Intelligence & Research
Skilling Programs
Internship
Case studies
Contact Us
Contribute Articles
Search
Home
Tags
Alembic Pharmaceuticals
Tag: Alembic Pharmaceuticals
Industry & Sector-Specific
Alembic Pharmaceuticals and Amlan International launch MinerTox-Z and MinerTox-A
Author
-
October 8, 2025
0
Health/ Lifestyle & Entertainment
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets
Passionate in Marketing
-
August 19, 2025
0
Branding/Advertising
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
Author
-
July 28, 2025
0
Business & Finance
Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint
Author
-
July 3, 2025
0
News & Reports
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
Author
-
May 2, 2025
0
Branding/Advertising
Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.
Passionate in Marketing
-
August 15, 2024
0
Branding/Advertising
Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg
Passionate in Marketing
-
July 5, 2024
0
Marketing Analytics
Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg
Passionate in Marketing
-
June 19, 2024
0
Branding/Advertising
Alembic Pharmaceuticals Receives 5 USFDA Product Approvals in Q1FY25
Passionate in Marketing
-
May 9, 2024
0
Marketing Analytics
Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) for its Oncology Formulation Facility at Panelav
Passionate in Marketing
-
May 6, 2024
0
1
2
Page 1 of 2